Literature DB >> 3288995

Dominant negative protein kinase mutations that confer a G1 arrest phenotype.

M D Mendenhall1, H E Richardson, S I Reed.   

Abstract

The CDC28 gene of Saccharomyces cerevisiae encodes a protein kinase that is required for passage through the G1 phase of the cell cycle. We have used an inducible promoter fused to the CDC28 coding sequence to isolate conditionally dominant mutant alleles of CDC28. Overexpression of these dominant alleles causes arrest in the G1 phase of the cell cycle but permits the distinctive asymmetric growth that is characteristic of recessive temperature-sensitive cdc28 mutants. The dominant alleles encode products with no detectable protein kinase activity, and their phenotypic effects can be suppressed by simultaneous overproduction of the wild-type protein. DNA sequence analysis showed that the mutant site in at least one of the dominant alleles is in a residue that is highly conserved among protein kinases. These properties are best understood if the dominant mutation results in the catalytic inactivation of the protein kinase but still allows the binding of another component needed for CDC28 function. By this model, high levels of the mutant protein arrest cell division by denying the wild-type protein access to this other component. Suppressors that may encode this other component have been isolated on high-copy-number plasmids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288995      PMCID: PMC280442          DOI: 10.1073/pnas.85.12.4426

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Sequence analysis of temperature-sensitive mutations in the Saccharomyces cerevisiae gene CDC28.

Authors:  A T Lörincz; S I Reed
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

2.  Local mutagenesis within deletion loops of DNA heteroduplexes.

Authors:  K W Peden; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Dual regulation of the yeast CDC28-p40 protein kinase complex: cell cycle, pheromone, and nutrient limitation effects.

Authors:  M D Mendenhall; C A Jones; S I Reed
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.

Authors:  M G Lee; P Nurse
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

5.  Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae.

Authors:  M Johnston; R W Davis
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

6.  The structure of transposable yeast mating type loci.

Authors:  K A Nasmyth; K Tatchell
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

7.  Sequence of the cell division gene CDC2 from Schizosaccharomyces pombe; patterns of splicing and homology to protein kinases.

Authors:  J Hindley; G A Phear
Journal:  Gene       Date:  1984-11       Impact factor: 3.688

8.  Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae.

Authors:  J Mellor; M J Dobson; N A Roberts; M F Tuite; J S Emtage; S White; P A Lowe; T Patel; A J Kingsman; S M Kingsman
Journal:  Gene       Date:  1983-09       Impact factor: 3.688

9.  Functionally homologous cell cycle control genes in budding and fission yeast.

Authors:  D Beach; B Durkacz; P Nurse
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

10.  Regulation of mating in the cell cycle of Saccharomyces cerevisiae.

Authors:  B J Reid; L H Hartwell
Journal:  J Cell Biol       Date:  1977-11       Impact factor: 10.539

View more
  28 in total

1.  Effect of the pheromone-responsive G(alpha) and phosphatase proteins of Saccharomyces cerevisiae on the subcellular localization of the Fus3 mitogen-activated protein kinase.

Authors:  Ernest Blackwell; Izabel M Halatek; Hye-Jin N Kim; Alexis T Ellicott; Andrey A Obukhov; David E Stone
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

2.  A dominant negative allele of p34cdc2 shows altered phosphoamino acid content and sequesters p56cdc13 cyclin.

Authors:  U N Fleig; K L Gould; P Nurse
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Expression of a dominant negative allele of cdc2 prevents activation of the endogenous p34cdc2 kinase.

Authors:  U N Fleig; P Nurse
Journal:  Mol Gen Genet       Date:  1991-05

4.  Stoichiometry of G protein subunits affects the Saccharomyces cerevisiae mating pheromone signal transduction pathway.

Authors:  G M Cole; D E Stone; S I Reed
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Targeting of signal sequenceless proteins for export in Escherichia coli with altered protein translocase.

Authors:  W A Prinz; C Spiess; M Ehrmann; C Schierle; J Beckwith
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Isolation, sequencing, and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae.

Authors:  R Padmanabha; J L Chen-Wu; D E Hanna; C V Glover
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Genetic analysis of the shared role of CLN3 and BCK2 at the G(1)-S transition in Saccharomyces cerevisiae.

Authors:  H Wijnen; B Futcher
Journal:  Genetics       Date:  1999-11       Impact factor: 4.562

8.  Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae.

Authors:  J M Nigro; R Sikorski; S I Reed; B Vogelstein
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  SLK1, a yeast homolog of MAP kinase activators, has a RAS/cAMP-independent role in nutrient sensing.

Authors:  C Costigan; M Snyder
Journal:  Mol Gen Genet       Date:  1994-05-10

Review 10.  Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae.

Authors:  M D Mendenhall; A E Hodge
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.